Cargando…

Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia

Detalles Bibliográficos
Autores principales:	Chen, Z, Medeiros, L J, Kantajian, H M, Zheng, L, Gong, Z, Patel, K P, Xiong, H, Wang, W, Cortes, J E, Hu, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386338/ https://www.ncbi.nlm.nih.gov/pubmed/28157214 http://dx.doi.org/10.1038/bcj.2017.4

Ejemplares similares

Current Management of Chronic Myeloid Leukemia Myeloid Blast Phase
por: Yohanan, Binoy, et al.
Publicado: (2022)

Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
por: Chen, Z, et al.
Publicado: (2016)

Extramedullary sudden blast crisis in chronic-phase chronic myeloid leukemia during first-line treatment with nilotinib
por: Angelopoulou, M K, et al.
Publicado: (2016)

B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
por: Yohannan, Binoy, et al.
Publicado: (2022)

Blast phase of chronic myeloid leukemia presenting as early T‐cell precursor lymphoblastic leukemia
por: Qiu, Lianqun, et al.
Publicado: (2021)

ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia
por: Menezes, J, et al.
Publicado: (2013)

Unusual T-Lymphoblastic Blast Phase of Chronic Myelogenous Leukemia
por: Xu, Jie, et al.
Publicado: (2014)

Pediatric chronic myeloid leukemia in myeloid blast crisis
por: Dey, Biswajit, et al.
Publicado: (2023)

Pyrvinium selectively targets blast phase-chronic myeloid leukemia through inhibition of mitochondrial respiration
por: Xiang, Wei, et al.
Publicado: (2015)

A rare case of B-lymphoid blast phase of chronic myeloid leukemia: Diagnostic challenges
por: Naiyer, Nada, et al.
Publicado: (2022)

Rapid and Deep Remission Induced by Blinatumomab for CD19-Positive Chronic Myeloid Leukemia in Lymphoid Blast Phase
por: Patel, Shyam A., et al.
Publicado: (2021)

Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo
por: Zhou, H, et al.
Publicado: (2017)

A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase
por: García-Gutiérrez, Valentin, et al.
Publicado: (2022)

Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia
por: Kassem, Nancy, et al.
Publicado: (2023)

Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation
por: Soliman, Dina S, et al.
Publicado: (2018)

A case report and case review: Chronic myeloid leukemia (CML) blast phase with myelomastocytic differentiation
por: Song, Jinming, et al.
Publicado: (2020)

Promyelocytic Blast Phase of Chronic Myeloid Leukemia, BCR-ABL1-Positive: Points to be Considered at Diagnosis
por: Kim, Bohyun, et al.
Publicado: (2021)

Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia
por: Shin, Ji Eun, et al.
Publicado: (2023)

Accelerated phase chronic myeloid leukemia: evaluation of clinical criteria as predictors of survival, major cytogenetic response and progression to blast phase
por: Furtado, Vanessa Fiorini, et al.
Publicado: (2015)

Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
por: Pietarinen, P O, et al.
Publicado: (2015)

Chronic phase of chronic myeloid leukemia presenting with myeloid sarcoma in an adolescent
por: Lee, Hee Jin, et al.
Publicado: (2020)

Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations
por: Sembill, Stephanie, et al.
Publicado: (2023)

Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia
por: Bidikian, Aram, et al.
Publicado: (2022)

Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity
por: Copland, Mhairi
Publicado: (2022)

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia
por: Gambacorti-Passerini, Carlo, et al.
Publicado: (2014)

Phase distribution of chronic myeloid leukemia in Bangladesh
por: Mottalib, Md Abdul, et al.
Publicado: (2014)

Management of Chronic Myeloid Leukemia in Advanced Phase
por: Bonifacio, Massimiliano, et al.
Publicado: (2019)

Prolonged Survival of a Patient with Chronic Myeloid Leukemia in Accelerated Phase with Recurrent Isolated Central Nervous System Blast Crisis
por: Bin Salman, Ahmed A., et al.
Publicado: (2020)

Chronic Myeloid Leukemia: Chronic Phase Presenting as Extramedullary Presentation
por: Nanote, Vedant A, et al.
Publicado: (2022)

Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia()
por: Lam Yi, Hui, et al.
Publicado: (2019)

RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses
por: Adnan Awad, Shady, et al.
Publicado: (2020)

Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase
por: Lee, Jae Wook, et al.
Publicado: (2021)

Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses
por: Wetzler, M, et al.
Publicado: (2015)

Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
por: Linga, Vijay Gandhi, et al.
Publicado: (2014)

Circulating endothelial cells are increased in chronic myeloid leukemia blast crisis
por: Godoy, C.R.T., et al.
Publicado: (2015)

Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate
por: Akard, Luke, et al.
Publicado: (2015)

Blast Phase Chronic Myelomonocytic Leukemia: Mayo-MDACC Collaborative study of 171 cases
por: Patnaik, Mrinal M., et al.
Publicado: (2018)

Atypical presentation of patients with chronic myeloid leukemia in chronic phase—Case report
por: Ramdohr, Florian, et al.
Publicado: (2022)

A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib
por: Tomassetti, Sarah, et al.
Publicado: (2022)

BH3 mimetics in combination with nilotinib or ponatinib represent a promising therapeutic strategy in blast phase chronic myeloid leukemia
por: Parry, Narissa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cdpdn0aoobad10ugp6oaaml6lm